Stock Events

Stock Events

Denali Therapeutics (D2NL34.SA) Q4 2023 Earnings

27FebConfirmed

Q4 2023

-4.24

-4.15

-4.06

-3.97

Details

Expected EPS

-3.9656298704000004

Actual EPS

-4.2418640000000005

Surprise EPS

-0.28

Surprise Percent

+6.97%

Description

Denali Therapeutics (D2NL34.SA) has reported earnings of -4.2418640000000005 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.